iCo Therapeutics (iCo Therapeutics) Total Inventories : $0.00 Mil (As of Mar. 2021)

View and export this data going back to 2009. Start your Free Trial

What is iCo Therapeutics Total Inventories?

iCo Therapeutics's total inventories for the quarter that ended in Mar. 2021 was $0.00 Mil. iCo Therapeutics's average total inventories from the quarter that ended in Dec. 2020 to the quarter that ended in Mar. 2021 was $0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. iCo Therapeutics's Net-Net Working Capital per share for the quarter that ended in Mar. 2021 was $0.00.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

iCo Therapeutics Total Inventories Historical Data

The historical data trend for iCo Therapeutics's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iCo Therapeutics Total Inventories Chart

iCo Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Total Inventories

Get a 7-Day Free Trial

iCo Therapeutics Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Total Inventories	Get a 7-Day Free Trial															-	-	-	-	-

iCo Therapeutics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

iCo Therapeutics (GREY:ICOTF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

iCo Therapeutics's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2021 is

	Net-Net Working Capital Per Share (Q: Mar. 2021 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1.673	+	0.75 * 0	+	0.5 * 0	-	1.528
-	0	-	0)	/	181.083
=	0.00

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

iCo Therapeutics's Days Inventory for the three months ended in Mar. 2021 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2021 )	/	Cost of Goods Sold (Q: Mar. 2021 )	*	Days in Period
	=	0	/	0	*	365 / 4
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

iCo Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2021 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Mar. 2021 )	/	Average Total Inventories (Q: Mar. 2021 )
	=	0	/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

iCo Therapeutics's Inventory to Revenue for the quarter that ended in Mar. 2021 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2021 )	/	Revenue (Q: Mar. 2021 )
	=	0	/	0
	=

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

iCo Therapeutics Total Inventories Related Terms

Thank you for viewing the detailed overview of iCo Therapeutics's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

iCo Therapeutics (iCo Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iCo Therapeutics Inc (GREY:ICOTF) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

777 Hornby Street, 6th Floor, Vancouver, BC, CAN, V6Z 1S4

Website

http://www.icotherapeutics.com

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

iCo Therapeutics (iCo Therapeutics) Headlines

No Headlines